Roisin Schimmel
Papers
2
Total Citations
346
H-Index
2
About
Roisin Schimmel is a leading clinical researcher in urologic oncology, with a primary focus on optimizing surgical outcomes for patients with bladder cancer. Her work centers on the comparative effectiveness and cost-efficiency of robot-assisted radical cystectomy (RARC) versus traditional open surgery. Schimmel’s landmark 2022 study, published in a top-tier journal, is a pivotal contribution to the field. Garnering over 320 citations, this randomized trial provided critical evidence on whether total intracorporeal robotic surgery improves 90-day morbidity and mortality compared to open radical cystectomy, directly addressing a key question in modern urology. Building on this, her 2023 cost-effectiveness analysis (26 citations) further clarified the value proposition of robotic surgery for healthcare payers, demonstrating a rigorous approach to evaluating both clinical and economic outcomes. By integrating high-level evidence on recovery, complications, and healthcare costs, Schimmel’s research helps guide surgical decision-making and policy in bladder cancer care. Her work is essential reading for surgeons, health economists, and trainees seeking to understand the real-world trade-offs of advanced surgical technologies.
Research Focus
Key Achievements
Top Papers
- 1
- 2